Xenon Pharmaceuticals Outlines Key Milestone Opportunities and Planned Leadership Transition in 2021
Simon Pimstone to Assume New Role as Executive Chair and Ian Mortimer to be Named Chief Executive Officer at Annual...
Key
The MarketWatch News Department was not involved in the creation of this content. Jan 14, 2021 (The Expresswire) -- Global...
The MarketWatch News Department was not involved in the creation of this content. Jan 14, 2021 (The Expresswire) -- Global...
By Reuters CommunicationsThe fourth and last working day of Reuters Following showcased a extensive-ranging team of influential leaders and thinkers...
Simon Pimstone to Assume New Role as Executive Chair and Ian Mortimer to be Named Chief Executive Officer at Annual...
The MarketWatch News Department was not involved in the creation of this content. Jan 14, 2021 (The Expresswire) -- Global...
The MarketWatch News Department was not concerned in the creation of this articles. Jan 13, 2021 (CDN Newswire through Comtex)...
The MarketWatch Information Department was not concerned in the creation of this written content. Jan 13, 2021 (CDN Newswire by...
The MarketWatch News Department was not involved in the creation of this content. Jan 14, 2021 (Heraldkeepers) -- The market...
The MarketWatch News Department was not involved in the creation of this content. Jan 13, 2021 (The Expresswire) -- Global...
The MarketWatch News Department was not involved in the creation of this content. Jan 13, 2021 (The Expresswire) -- Global...
The MarketWatch News Department was not involved in the creation of this content. Jan 13, 2021 (The Expresswire) -- Global...
The MarketWatch News Department was not involved in the creation of this content. Jan 13, 2021 (The Expresswire) -- Global...
The MarketWatch Information Division was not included in the creation of this content. January 12, 2021 (ACCESSWIRE by means of...
The MarketWatch News Department was not involved in the creation of this content. Jan 12, 2021 (The Expresswire) -- "Final...
The MarketWatch News Department was not involved in the creation of this content. Jan 12, 2021 (The Expresswire) -- "Final...
The MarketWatch Information Department was not included in the generation of this content material. Jan 11, 2021 (Heraldkeepers) -- Good...
The MarketWatch News Department was not involved in the creation of this content. Jan 12, 2021 (The Expresswire) -- Fortune...
The MarketWatch News Department was not involved in the creation of this content. Jan 11, 2021 (The Expresswire) -- "Pest...
Commercial launch activities for Idefirix® progressing as planned Patient recruitment in the two phase 2 studies in AMR and GBS was...
